🇺🇸 FDA
Patent

US 8975243

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

granted A61KA61K31/573A61K31/58

Quick answer

US patent 8975243 (Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract) held by The Regents of the University of California expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
59
CPC classes
A61K, A61K31/573, A61K31/58, A61K47/26, A61K9/0056